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To the Editor: I read with interest the article by 
Khan et al. (1). The National Vector-borne Disease Con-
trol Program reported >60,000 cases of acute encephali-
tis syndrome (AES) in India during 2010–2016; 8 states 
(Assam, Uttar Pradesh, West Bengal, Odisha, Tamil 
Nadu, Karnataka, Manipur, and Tripura) accounted for 
most cases (2). In many states, outbreaks of AES oc-
cur during the rainy season and are associated with high 
mortality rates. Following the national surveillance al-
gorithm, AES cases are investigated for IgM against 
Japanese encephalitis, which accounted for <15% AES 
cases. Khan et al. reported 20% of AES cases were due 
to scrub typhus (Orientia tsutsugamushi infection) (1). 
In Gorakhpur, Uttar Pradesh, 62.7% of AES patients had 
O. tsutsugamushi IgM, with a case-fatality rate of 16.2% 
(3). Studies have reported central nervous system (CNS) 
involvement among a substantial number of scrub typhus 
patients from Dehradun, Uttarakhand; Vellore, Tamil 
Nadu; Puducherry; and Lucknow, Uttar Pradesh (4,5). 
Given these findings, managers of the national program 
should consider investigations for scrub typhus as part 
of the surveillance algorithm for AES cases.
Higher mortality rates among patients with AES 
could be attributed to delayed care. In Gorakhpur, where 
outbreaks of AES occur seasonally, the median interval 
between fever onset and hospitalization was 7 days (IQR 
5–10 days) (3). Although intravenous azithromycin has 
been recommended for AES patients in Gorakhpur since 
2014, fatality rates continue to be high, indicating low re-
sponse to treatment after CNS involvement. Early treat-
ment of patients with acute febrile illness with antimicrobi-
al drugs such as doxycycline before CNS manifestations is 
critical. Assessing the contribution of scrub typhus among 
patients with acute febrile illness, developing algorithms 
for administering appropriate antimicrobial drugs, and edu-
cating healthcare providers about the use of doxycycline 
are crucial for reducing deaths among patients with AES in 
scrub typhus–endemic areas.
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